H1N1 influenza vaccine (Xenetic Biosciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameH1N1 influenza vaccine (Xenetic Biosciences)

Drug Alias NameH1N1 influenza vaccine (Lipoxen)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesXenetic Biosciences (Uk) Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesXenetic Biosciences (Uk) Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A